Australia markets closed

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
64.35+0.49 (+0.77%)
As of 12:16PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close63.86
Open63.68
Bid64.39 x 800
Ask64.40 x 800
Day's range63.25 - 64.46
52-week range53.22 - 69.75
Volume3,918,506
Avg. volume13,470,233
Market cap142.834B
Beta (5Y monthly)0.63
PE ratio (TTM)N/A
EPS (TTM)-2.42
Earnings date04 Feb 2022
Forward dividend & yield2.16 (3.47%)
Ex-dividend date06 Jan 2022
1y target est72.22
  • Business Wire

    Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B

    PRINCETON, N.J., January 28, 2022--BMS Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B

  • Motley Fool

    2 Dirt-Cheap Dividend Stocks to Buy and Hold Forever

    Dividend stocks are worth serious consideration, especially given the current state of the economy. Let's look at two companies to consider -- both of which are excellent, dividend-paying companies and look like steals at current levels: AbbVie (NYSE: ABBV) and Bristol Myers Squibb (NYSE: BMY). Pharma giant AbbVie offers a dividend yield of 4.01%, significantly higher than the S&P 500's average of 1.27%.

  • Motley Fool

    What's the Outlook for Illumina?

    Genomic sequencing leader Illumina (NASDAQ: ILMN) recently provided guidance for 2022 and revealed some of its plans for the year. In this Motley Fool Live video, recorded on Jan. 12, Fool contributors Keith Speights and Brian Orelli discuss the outlook for Illumina going forward. Keith Speights: Hey, there's a company that you and I haven't talked about very much, at least, I'm going to say at least over the last seven or eight months and maybe longer than that.